HIV infection: Recommendations for the management of asymptomatic adults and selected clinical syndromes;Infección por VIH: Recomendaciones para el manejo del adulto asintomático y de algunos síndromes clínicos

Revista Medica de Chile

Volumn 124, Issue 8, 1996, Pages 983-998

  Wolff R, Marcelo ^a   Northland A, Rebeca ^a  

^a NONE

Author keywords

Carrier state; Diagnosis, clinical; Drug therapy; Health education; HIV infection

Indexed keywords

ADULT; AIDS RELATED COMPLEX; CLINICAL PROTOCOL; HETEROZYGOTE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 2; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; PROSPECTIVE STUDY; REVIEW;

ADULT; AIDS-RELATED OPPORTUNISTIC INFECTIONS; CARRIER STATE; CLINICAL PROTOCOLS; HIV INFECTIONS; HIV-1; HIV-2; HUMANS; PROSPECTIVE STUDIES;

EID: 0030202088     PISSN: 00349887     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. World Health Organization: Global programme on AIDS. The HIV/AIDS pandemic: 1994 overview (WHO/GPA/TCO/SEF/94.4) 1994.
2. GREENBERG AE, THOMAS PA, LANDESMAN SH, ET AL. The spectrum of HIV-1 related disease among outpatients in New York City. AIDS 1992; 6: 849-59.
3. KELLY MP. Clinical manifestation of African AIDS. Br J Hosp Med 1992; 48: 734-7,740-1.
4. WOLFF M, NORTHLAND R, SEGOVIA J, ET AL. Características clínicas e historia natural de la infección por Virus de Inmunodeficiencia Humana. Estudio en una población chilena atendida en un centro piloto multiprofesional. Rev Méd Chile 1995; 123: 61-73.
5. MINISTERIO DE SALUD, COMISION NACIONAL DE SIDA; Boletín Epidemiológico. CONASIDA 1984-1994. (En prensa).
6. ORGANIZACION PANAMERICANA DE LA SALUD. Programa Regional de SIDA/ETS. División de Prevención y Control de Enfermedades Transmisibles. Vigilancia Epidemiológica del SIDA en las Américas. Informe trimestral. 10 de Diciembre, 1993.
7. MURILLO J, CASTRO K. HIV infection and AIDS in Latin America. Epidemiologic features and clinical manifestations. Infect Dis NA 1994; 8: 1-11.
8. WORLD HEALTH ORGANIZATION. Global Programme on AIDS. Guidelines for the clinical management of HIV infections in adults (WHO/GPA/IDS/HCS/91.6). December, 1992.
9. OPS. Pautas para la atención de la persona adulta infectada por el VIH. Programa Regional de SIDA y ETS. División de Prevención y Control de Enfermedades. Organización Panamericana de la Salud. 1994.
10. MANSUR H. Management of opportunistic infections associated with HIV infection. In: Mandell, Douglas and Bennett's (Editors). Principles and Practice of Infections Diseases. 4th ed. Churchill Livingstone Inc: New York. 1995.
11. SANFORD J, SANDE M, GILBERT D, GERBERDING JL. Guide to HIV/AIDS therapy 1994. Antimicrobial Therapy Inc. Dallas, Texas. 1994.
12. KAPLAN J, MANSUR H, HOLMES KK ET AL AND THE USPHS/AIDS PREVENTION OF OPPORTUNISTIC INFECTIONS WORKING GROUP. USPH/AIDS Guidelines for the prevention of opportunistic infections in persons infected with the Human Immunodeficiency Virus. Clin Infect Dis 1995; (Suppl): S 12-32.
13. FOURNIER AM, SOSENKO JM. The relationship of total lymphocyte counts to CD4 lymphocyte counts in patients infected with human immunodeficiency virus. Am J Med Sci 1992; 304: 79-82.
14. BLATT SP, LUCEY CR, BUTAIN CA, HENDRIX CW, LUCEY DR. Total lymphocyte count as a predictor of absolute CD4+ count and CD4+ percentage in HIV- infected persons. JAMA 1993; 269: 622-6.
15. HOOVER DR, SAAH AJ, BAULLER H, ET AL. Clinical manifestation of AIDS in the era of pneumocytis prophylaxis. N Engl J Med 1993; 329: 1922-26.
16. GLUCKSTEIN D, RUSKIN J. Rapid oral desensitizacion to trimethoprim-sulfamethoxazole (TMP-SMZ): use in prophylaxis for Pneumocystis carinii pneumonia in patients with AIDS who were previously intolerant to TMP-SMZ. Clin Infect Dis 1995; 20: 849-53.
17. HOPEWELL PC. Impact of human immunodeficiency virus infection on the epidemiology, clinical features, management and control of tuberculosis. Clin Infec Dis 1992; 15: 540-47.
18. SMALL PM, SHAFER RW, HOPEWELL PC. Exogenous reinfection with multidrug-resistant Mycobacterium tuberculosis in patients with advanced HIV infection. N Engl J Med 1995; 328: 1137-40.
19. PAPE JW, JEAN SS, HO JL, HAFNER A, JOHNSON WD JR. Effect of isoniacid prophylaxis on incidence of active tuberculosis and progression of HIV infection. Lancet 1993; 342: 268-72.
20. CENTERS FOR DISEASE CONTROL AND PREVENTION. Purified Protein Derivate (PPD)- Tuberculine anergy and HIV: guidelines for anergy testing and management of anergic persons at risk tuberculosis. MMWR 1991; 40 (Suppl RR 5): 27-33.
21. CONCORDE COORDINATING COMMITTEE. Concorde: MCR/ANRS randomised double-blind controlled trial of immediate and deferred zidovudine in symptom-free HIV infection. Lancet 1994; 343: 871-81.
22. 3. In Program Addendum (LB-1). Interscience Conference on Antimicrobial Agents and Chemoteraphy. San Francisco 17-20 Septiembre, 1995.
23. NORTHLAND R, WOLFF M, BELTRAN C ET AL. Infección por Virus de Inmunodeficiencia Humana (VIH) en mujeres chilenas. Rev Chile Infect 1993; 10: 151-7.
24. POLSKY B, GOLD JW, WHIMBERY E ET AL. Bacterial pneumonia in patients with the acquiried immunodeficiency syndrome. Ann Intern Medt 1986; 104: 38-41.
25. PHAIR J, MUÑOZ A, DETELS ET AL. The risk of Pneumocystis carinii pneumonia among men infected with human immunodeficiency virus type 1. N Engl J Med 1990; 322: 161-5.
26. MEDURI GU, STEIN DS. Pulmonary manifestations of acquired immunodeficiency syndrome. Clin Infect Dis 1992; 14: 98-113.
27. LUFT BJ, REMINGTON JS. Toxoplasmic encephalitis in AIDS. Clin Infect Dis 1992; 15: 211-22.
28. CARR A, TINDELL B, BREW ET AL. Low-dose trimetroprim-sulphamethoxazole prophylaxis for toxoplasmic encephalitis in patients with AIDS. Ann Intern Med 1992; 117: 106-11.